MedyMatch Technology announces new chairman and CEO, new office in Boston

Michael Walter | | Radiology Business | Medical Imaging

New healthcare startup MedyMatch Technology, which specializes in using both cognitive analytics and artificial intelligence, has announced the addition of Gene Saragnese as its chairman and CEO. Saragnese previously worked as the CEO of Philips Imaging Systems, a division of Philips Healthcare.

"I am thrilled to be joining the Company in this capacity and at this time in its history," Saragnese said in a prepared statement. "MedyMatch's unique ability to deliver better clinical care at lower cost is exceptionally positioned in the industry, and our technology, artificial intelligence based image classification, will provide physicians with the deep contextual patient insights they need to make the right assessment in challenging acute care settings, when every minute is critical."

In addition, MedyMatch also announced it is opening an office in Boston, which will be the company’s first in the U.S. Its global headquarters are located in Tel Aviv, Israel.

MedyMatch also used the announcement to officially share its goal of improving the performance of real-time support tools in healthcare. According to the statement, the company's products can help radiologists and emergency department physicians make faster diagnoses when combined with standard emergency room imaging platforms. 

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

U.S. moves closer to establishing domestic supply of Mo-99 for nuclear imaging
RSNA 2024 Program Chair Kate Hanneman highlights key trends in radiology
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage
Radiologists are more accurate, confident when they know the full story
GE HealthCare moves PET/CT scanner production to United States
Use of AI opportunistic screening in CT for cardiovascular disease

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.